Navigation Links
American Association of Radon Scientists and Technologists (AARST) Releases Nation's First Standard for Mitigating Radon (Radioactivity) in Multifamily Buildings
Date:2/1/2013

Fletcher, North Carolina (PRWEB) February 01, 2013

The AARST Consortium on National Radon Standards has announced the release of a Provisional American National Standard for radon mitigation professionals entitled, "Radon Mitigation Standards In Multifamily Buildings." The new document establishes preliminary standards for mitigating multifamily housing in the United States.

The American Association of Radon Scientists and Technologists (AARST) believes this material necessary for fixing the problem of radon exposure (radioactivity) in multi-family housing.

“Up until now," said Gary Hodgden, Chair of the Executive Stakeholder Committee at AARST’s Standards Organization, “we have been witnessing that building owners and occupants of multifamily buildings are conducting radon testing but are faced with a problem. No standards or guidance documents have existed for mitigating radon (radioactivity) from apartments or multifamily dwellings.”

"I am happy to report that a document now exists to help remedy that situation.

"This guidance document will save American lives.”

“According to the US census in 2000, approximately 25% of Americans live in multifamily buildings that include condos or apartments. AARST members have found that risks associated with radon gas (radioactivity) in single family homes are also found in multifamily buildings in those same areas. That is a large portion in the United States. As more of these millions of families test for radon (radioactivity), the need for appropriate mitigation guidance has grown.”

Hodgden said the standard will be undergoing the consensus standards development process following AARST’s accredited procedures towards final publication within two years as a completed American National Standard (ANS.)

“AARST will be beginning the public review process to ensure this document also becomes a full consensus standard under the accreditation of the American National Standards Institute.”

AARST Executive Director Peter Hendrick has said that testing and mitigating multifamily housing for radon will reduce not only health risks but will reduce liability for apartment managers, developers and the multifamily housing sector.

"This is both a health risk issue and a risk management issue for the housing sector," said Hendrick.

AARST estimates that over 8 million American homes and 70,000 classrooms have high levels of radon in them.

The American Association of Radon Scientists and Technologists is an ANSI accredited standards writing organization and they have previously produced and published an American National Standard for multifamily measurement: "The ANSI-AARST Protocol for Conducting Radon and Radon Decay Product Measurements in Multifamily Buildings."

The mitigation guidance document was processed in accordance with AARST requirements for stakeholder balance and consensus within the RMS-MF subcommittee assigned to Radon Mitigation Standards for Multifamily Buildings.

The new standard will be available online at AARST Bookstore,

AARST is a non-profit professional association dedicated to high standards of practice for testing and mitigation of radon in homes and commercial buildings.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10357643.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. American College of Cardiology cites new USF Simulation Center for Training Excellence
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. Young Americans Need to Cut Calorie Intake: Study
5. Hutchinson Center president elected to American Academy of Art and Sciences
6. Can weight loss help African-American breast cancer survivors?
7. Americans Support Medicare Reform, But Not on Their Dime: Poll
8. One-third of adult Americans with arthritis battle anxiety or depression
9. Equal access to care helps close survival gap for young African-American cancer patients
10. Systemic sclerosis complications more severe in African Americans than Caucasians
11. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... Only two months after the official release of The Private Collection – Edition ... has initiated a second print-run of its lavish luxury travel coffee table book. ... weighs in at more than six kilos, retails at EUR 1,000 per copy and ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... and hearing disabilities, it is so critically important that we all are aware ... That is why Mediaplanet is proud to announce the launch of its newest ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
Breaking Medicine Technology: